Literature DB >> 6305951

Interferon induction of fibroblast proteins with guanylate binding activity.

Y S Cheng, R J Colonno, F H Yin.   

Abstract

Treatment of human diploid fibroblastic cells with interferon induces the synthesis of two guanylate binding proteins (GBP) with molecular weights of 67,000 and 56,000. The Mr = 67,000 protein (67K GBP) is synthesized upon treatment with either alpha-, beta-, or gamma-interferon. Among these interferons, gamma-interferon induces a higher level of 67K GBP synthesis. The 67K GBP synthesized in either beta- or gamma-interferon-treated cells has two charge forms with isoelectric points of 6.0 and 5.8, respectively. The synthesis of the Mr = 56,000 protein is induced by the treatment using either alpha- or beta-interferon, but its synthesis in gamma-interferon-treated cells is undetectable. The amounts of the radioactive GBPs synthesized in human fibroblasts are proportional to the amounts of the purified beta-interferon used for the inductions. Syntheses of GBPs require the transcription of cellular genes because their syntheses are completely blocked by actinomycin D treatments. The mRNA for the 67K GBP is found in fibroblasts that are treated by either alpha-, beta-, or gamma-interferon, but it is not detected in untreated cells. More 67K GBP mRNA is accumulated in the gamma-interferon-treated than in alpha- or beta-interferon-treated fibroblasts. This is consistent with more 67K GBP synthesis found in gamma-interferon-treated fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305951

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice.

Authors:  Karoline Lipnik; Elisabeth Naschberger; Nathalie Gonin-Laurent; Petra Kodajova; Helga Petznek; Stefanie Rungaldier; Simonetta Astigiano; Silvano Ferrini; Michael Stürzl; Christine Hohenadl
Journal:  Mol Med       Date:  2010-02-05       Impact factor: 6.354

2.  Dimerization and its role in GMP formation by human guanylate binding proteins.

Authors:  Nazish Abdullah; Meena Balakumari; Apurba Kumar Sau
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

Review 3.  Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections.

Authors:  Kelly J Pittman; Laura J Knoll
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

4.  Immunity-related GTPase M (IRGM) proteins influence the localization of guanylate-binding protein 2 (GBP2) by modulating macroautophagy.

Authors:  Maria K Traver; Stanley C Henry; Viviana Cantillana; Tim Oliver; Julia P Hunn; Jonathan C Howard; Sandra Beer; Klaus Pfeffer; Jörn Coers; Gregory A Taylor
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

5.  Structure of the caspase-recruitment domain from a zebrafish guanylate-binding protein.

Authors:  Tengchuan Jin; Mo Huang; Patrick Smith; Jiansheng Jiang; T Sam Xiao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-07-27

6.  Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-γ signal transduction pathways.

Authors:  Dan Li; Jin Wei; Fan Yang; Hua-Nan Liu; Zi-Xiang Zhu; Wei-Jun Cao; Shu Li; Xiang-Tao Liu; Hai-Xue Zheng; Hong-Bing Shu
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

7.  Alpha interferon and gamma interferon stimulate transcription of a single gene through different signal transduction pathways.

Authors:  D J Lew; T Decker; J E Darnell
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

8.  Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis.

Authors:  M Schnoor; A Betanzos; D A Weber; C A Parkos
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

9.  Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication.

Authors:  Daniel Degrandi; Elisabeth Kravets; Carolin Konermann; Cornelia Beuter-Gunia; Verena Klümpers; Sarah Lahme; Eva Rasch; Anne K Mausberg; Sandra Beer-Hammer; Klaus Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

Review 10.  Shaping future strategies for the pharmacological control of tumor cell metastases.

Authors:  R G Greig; D L Trainer
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.